Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.
The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a new class of nanomolar FKBP12 ligands.
Mixed Panniculitis Secondary to Interferon Beta-1a Therapy in a Woman With Multiple Sclerosis.
Cannabis-based medicines in multiple sclerosis--a review of clinical studies.
Mapi Pharma granted United States patent covering the process for the preparation of fingolimod for multiple sclerosis
Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.
Role of IL-16 in CD4(+) T cell-mediated regulation of relapsing multiple sclerosis.
On the Epidemiology of Multiple Sclerosis in the Middle East and North Africa.
Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis.
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.
Fine-Tuning S1P Therapeutics.
Prevalence and clinical features of multiple sclerosis in Latin America.
Incidence of multiple sclerosis in multiple racial and ethnic groups.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors.
The grey matter correlates of impaired decision-making in multiple sclerosis.
Interferon Beta and Glatiramer Acetate Therapy.
T Cell Apoptosis and Induction of Foxp3+ Regulatory T Cells Underlie the Therapeutic Efficacy of CD4 Blockade in Experimental Autoimmune Encephalomyelitis.
In vivo detection of experimental optic neuritis by pupillometry.
The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
In Vitro and In Vivo Models of Multiple Sclerosis.
Antibodies to potassium channels in multiple sclerosis.
Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
The antibody response to Epstein-Barr virions is altered in multiple sclerosis.
Sexual disorders in men with multiple sclerosis: Evaluation and management.
Pages
« first
‹ previous
…
220
221
222
223
224
225
226
227
228
…
next ›
last »